NEW YORK, April 22, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Intrexon Corporation ("Intrexon" or the "Company") (NYSE: XON), concerning whether the board has breached its fiduciary duties to shareholders.
On April 21, 2016, an online report was published alleging that the Company's technology has been questioned by officials of the World Health Organization, the Centers for Disease Control and Prevention, and the National Institutes of Health. The report also alleged that the Company has overstated revenues by 50% through accounting tricks.
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Intrexon shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.